文献速递复苏、休克与脓毒症创伤与烧伤呼吸衰竭与机械通气

冻干血小板促进血凝块形成、减轻内皮细胞通透性并减少失血性休克小鼠模型肺血管渗漏

Freeze-dried platelets promote clot formation, attenuate endothelial cell permeability, and decrease pulmonary vascular leak in a murine model of hemorrhagic shock.
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论小鼠失血性休克模型中,冻干血小板可促进凝血并减轻肺血管渗漏,效果类似鼠全血,而新鲜人血小板未减轻渗漏。

该研究在小鼠失血性休克模型中比较乳酸林格液、冻干人血小板、新鲜人血小板、鼠全血和假手术组的凝血、肺血管通透性和肺损伤。冻干血小板表达血小板标志物且功能类似新鲜血小板,体内可掺入血凝块。与休克-LR组相比,冻干血小板和鼠全血减轻肺血管通透性,新鲜人血小板(1-3天)未减轻血管渗漏。提示冻干血小板可能作为新鲜血小板的替代选择来调节止血和损伤相关内皮病。

要点

  • 小鼠失血性休克模型中,休克-LR组肺血管通透性为2637±954.7,显著高于假手术组686.6±359.7(p=0.001)。
  • 冻干血小板组肺血管通透性1328±462.6,较休克-LR组降低(p=0.05);鼠全血组1024±370.5,较休克-LR组降低(p=0.0108)。
  • 新鲜人血小板(1-3天)组肺血管通透性3601±1581,与休克-LR组相比无显著差异(p=0.33)。
  • 冻干血小板表达血小板特异性标志物,体外聚集功能与新鲜血小板类似但存在差异;体内可掺入小鼠提睾肌毛细血管后微静脉的血凝块。
  • 冻干血小板在体外和体内均减轻血管通透性;鼠全血但非新鲜人血小板在失血性休克后减轻血管通透性。

适用人群与场景

  • 小鼠失血性休克模型:控制性出血90分钟的小鼠。
  • 研究分组:乳酸林格液组、冻干人血小板组、新鲜人血小板组、鼠全血组、假手术组(仅器械操作)。
  • 原文未提及急诊/ICU患者人群的纳入或排除标准。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:小鼠失血性休克模型实验研究;样本量原文未明确给出。
  • 冻干血小板表达血小板特异性标志物,功能类似新鲜血小板;体外聚集试验中与新鲜血小板存在差异。
  • 体内:冻干血小板和新鲜血小板均可掺入小鼠提睾肌毛细血管后微静脉的血凝块。
  • 肺血管通透性:假手术组686.6±359.7 vs 休克-LR组2637±954.7(p=0.001),休克-LR组升高。
  • 冻干血小板组1328±462.6 vs 休克-LR组2637±954.7(p=0.05),冻干血小板组降低。
  • 鼠全血组1024±370.5 vs 休克-LR组2637±954.7(p=0.0108),鼠全血组降低。
  • 新鲜人血小板(1-3天)组3601±1581 vs 休克-LR组2637±954.7(p=0.33),无显著差异。

证据类型、等级与局限

  • 证据类型:动物实验研究(小鼠模型)。
  • 原文未述局限性。

对床旁实践的改变

  • 原文数据提示冻干血小板可能作为新鲜血小板的合适替代选择,用于调节止血和损伤相关内皮病,但仅基于小鼠模型,原文未提及临床适用人群或实践改变。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Hemorrhagic shock (HS) and trauma induce endothelial barrier compromise, inflammation, and aberrant clotting. We have shown that fresh human platelets (Plts) and Plt extracellular vesicles mitigate vascular leak in murine models of injury. Here, we investigate the potential of freeze-dried platelets (FDPlts) to attenuate pulmonary vascular permeability, decrease inflammation, and promote clotting in a murine model of HS.

METHODS: Human FDPlts were characterized using in vitro assays of Plt marker expression, aggregation, coagulation, and endothelial cell permeability. An intravital model of vascular injury in the mouse cremaster muscle was used to assess the ability of FDPlts to incorporate into clots. Mouse groups subjected to controlled hemorrhage for 90 minutes were (1) lactated Ringer solution (LR), (2) FDPlts, (3) fresh human Plts, (4) murine whole blood (WB), and (5) shams (only instrumented). Hemorrhagic shock mouse endpoints included coagulation, pulmonary vascular permeability, and lung injury.

RESULTS: Freeze-dried Plts expressed Plt-specific markers and retained functionality similar to fresh Plts. In in vitro assays of Plt aggregation, differences were noted. In vivo, FDPlts and Plts were found to incorporate into clots in postcapillary venules in the mouse cremaster muscle. Hemorrhagic shock mice resuscitated with LR displayed increased pulmonary vascular permeability compared with sham (sham, 686.6 ± 359.7; shock-LR, 2,637 ± 954.7; p = 0.001), and treatment with FDPlts or WB attenuated permeability compared with shock: shock-FDPlts, 1,328 ± 462.6 (p = 0.05), and shock-WB, 1,024 ± 370.5 (p = 0.0108). However, human Plts (Days 1-3) did not attenuate vascular leak in HS mice compared with shock-LR (shock-Plts, 3,601 ± 1,581; p = 0.33).

CONCLUSION: FDPlts contribute to clot formation similar to fresh human Plts. FDPlts also attenuated vascular permeability in vitro and in vivo. Mouse WB resuscitation but not fresh human Plts attenuated vascular permeability after HS. These data suggest that the effect of FDPlts may be a suitable alternative to fresh Plts in modulating hemostasis and the endotheliopathy associated with injury.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Trivedi A, Potter DR, Miyazawa BY, et al. Freeze-dried platelets promote clot formation, attenuate endothelial cell permeability, and decrease pulmonary vascular leak in a murine model of hemorrhagic shock. J Trauma Acute Care Surg. 2021. PMID: 33060537. doi:10.1097/TA.0000000000002984

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。